Article Text

Download PDFPDF
Clinical manifestations and outcome of tuberculous sclerokeratitis
  1. Samir S Shoughy1,
  2. Mahmoud O Jaroudi1,
  3. Khalid F Tabbara1,2,3
  1. 1The Eye Center and The Eye Foundation for Research in Ophthalmology, Riyadh, Saudi Arabia
  2. 2Department of Ophthalmology, College of Medicine, King Saud University, Riyadh, Saudi Arabia
  3. 3The Wilmer Ophthalmological Institute of The Johns Hopkins University, School of Medicine, Baltimore, Maryland, USA
  1. Correspondence to Dr Samir S Shoughy, Department of Ophthalmology, The Eye Center and The Eye Foundation for Research in Ophthalmology, The Eye Center, P. O. Box 55307, Riyadh 11534, Saudi Arabia; samir.shawki{at}


Aim To study the clinical manifestations and outcome of patients with tuberculous sclerokeratitis treated with antituberculous therapy without concomitant use of systemic steroids.

Methods We reviewed retrospectively the medical records of eight consecutive patients with tuberculous sclerokeratitis. Patients were treated unsuccessfully with topical and/or systemic steroids. They underwent complete ophthalmic examination, systemic evaluation, laboratory investigations and imaging. Tuberculin skin test was done with purified protein derivative (PPD) on all patients. The diagnosis of tuberculous sclerokeratitis was made based on clinical findings of scleritis with adjacent peripheral corneal stromal keratitis, positive PPD test of 15 mm of induration or more, response to antituberculous treatment (ATT) within 4 weeks and exclusion of other causes of sclerokeratitis. Antituberculous drugs were given for a minimum of 6 months without concomitant use of corticosteroids. The outcome measure was resolution of the ocular surface inflammation of the sclera and cornea.

Results Eight consecutive patients with a diagnosis of tuberculous sclerokeratitis were included. There were one male and seven female patients. The mean age was 29 years with an age range of 7–43 years. The involvement of the sclera was nodular in six patients and diffuse in two. The involvement of the cornea consisted of peripheral corneal stromal inflammation adjacent to the area of scleritis. Patients responded to antituberculous medications with complete resolution of the sclerokeratitis without topical or systemic anti-inflammatory agents.

Conclusions Antituberculous medications can lead to complete resolution of the sclerokeratitis without concomitant use of steroids, or other anti-inflammatory agents.

  • Inflammation
  • Ocular surface
  • Sclera and Episclera

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles

  • At a glance
    Keith Barton James Chodosh Jost Jonas